538 related articles for article (PubMed ID: 15094595)
1. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
2. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
3. Use of immunohistochemistry in diagnosis of breast epithelial lesions.
Bhargava R; Dabbs DJ
Adv Anat Pathol; 2007 Mar; 14(2):93-107. PubMed ID: 17471116
[TBL] [Abstract][Full Text] [Related]
4. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
5. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
[TBL] [Abstract][Full Text] [Related]
6. Synchronous bilateral Paget's disease of the nipple associated with bilateral breast carcinoma.
Franceschini G; Masetti R; D'Ugo D; Palumbo F; D'Alba P; Mulè A; Costantini M; Belli P; Picciocchi A
Breast J; 2005; 11(5):355-6. PubMed ID: 16174159
[No Abstract] [Full Text] [Related]
7. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
[TBL] [Abstract][Full Text] [Related]
8. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
[TBL] [Abstract][Full Text] [Related]
9. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
[TBL] [Abstract][Full Text] [Related]
10. Surrounding ipsilateral eruptive seborrheic keratosis as a warning sign of intraductal breast carcinoma and Paget's disease (Leser Trelat sign).
Shamsadini S; Wadji MB; Shamsadini A
Dermatol Online J; 2006 Oct; 12(6):27. PubMed ID: 17083907
[TBL] [Abstract][Full Text] [Related]
11. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
12. Contemporaneous H&E sections should be standard practice in diagnostic immunopathology.
Hoda SA; Rosen PP
Am J Surg Pathol; 2007 Oct; 31(10):1627. PubMed ID: 17895767
[No Abstract] [Full Text] [Related]
13. Paget's disease of the nipple diagnosed on cytology: a case report.
Bhadani PP; Sharma MC; Sah SP; Agarwal A
Indian J Pathol Microbiol; 2004 Apr; 47(2):246-8. PubMed ID: 16295486
[TBL] [Abstract][Full Text] [Related]
14. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of cell-nuclear DNA determination in aspiration cytology of benign and malignant lesions of the breast.
Sprenger E; Ulrich H; Schöndorf H
Anal Quant Cytol; 1979; 1(1):29-36. PubMed ID: 232644
[No Abstract] [Full Text] [Related]
16. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA
Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650
[TBL] [Abstract][Full Text] [Related]
17. Borderline breast lesions: diagnostic challenges and clinical implications.
Masood S; Rosa M
Adv Anat Pathol; 2011 May; 18(3):190-8. PubMed ID: 21490436
[TBL] [Abstract][Full Text] [Related]
18. The cytologic diagnosis of breast aspirations.
Wilson SL; Ehrmann RL
Acta Cytol; 1978; 22(6):470-5. PubMed ID: 216199
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
MacGrogan G
Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
[No Abstract] [Full Text] [Related]
20. Proliferative lesions of the breast: carcinoma in situ.
Chinoy RF
Indian J Pathol Microbiol; 2003 Apr; 46(2):153-64. PubMed ID: 15022899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
